ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOWA COMPANY, LTD.
  3. Financials
  4. Total non-current assets

KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
SummaryFinancialsDividendsHistoryWorkforce
Period EndTotal non-current assets (Million JPY)YoY (%)
Mar 31, 2023246,355-2.83%
Mar 31, 2022253,533-0.03%
Mar 31, 2021253,619+16.11%
Mar 31, 2020218,423+10.98%
Mar 31, 2019196,807+3.36%
Mar 31, 2018190,402+4.00%
Mar 31, 2017183,086-1.16%
Mar 31, 2016185,226-3.90%
Mar 31, 2015192,745-0.41%
Mar 31, 2014193,538+7.85%
Mar 31, 2013179,457

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat